Literature DB >> 20409561

Occurrence of basophilic inclusions and FUS-immunoreactive neuronal and glial inclusions in a case of familial amyotrophic lateral sclerosis.

Zen Kobayashi1, Kuniaki Tsuchiya, Tetsuaki Arai, Masashi Aoki, Masato Hasegawa, Hideki Ishizu, Haruhiko Akiyama, Hidehiro Mizusawa.   

Abstract

Basophilic inclusions (BIs) are the pathological feature in a subset of frontotemporal lobar degeneration (FTLD), sporadic amyotrophic lateral sclerosis (SALS) and familial ALS (FALS) cases. Mutations in the fused in sarcoma (FUS) gene have been recently identified as the cause of FALS type 6. FUS-immunoreactive (ir) inclusions are consistently found in cases of FTLD with BIs, but the association between ALS cases with BIs and FUS accumulation is still not well understood. In this study, we immunohistochemically analyzed the autopsied case of FALS with BIs using anti-FUS antibodies. The case was a 42-year-old woman who developed proximal weakness of the bilateral upper limbs, followed by weakness of other parts including the bulbar regions, and died at age 45. Since this case is a member of a family with FALS harboring the R521C mutation of the FUS gene, she may have carried the same FUS mutation. Histopathologically, neuronal loss was evident in the motor system and other areas including the cuneate nucleus of the medulla oblongata. BIs appeared in the brain stem, cerebellum and anterior horn of the lumbar cord. FUS-ir neuronal cytoplasmic inclusions, glial cytoplasmic inclusions and dystrophic neurites were more abundantly and widely occurring than BIs, especially in the cuneate nucleus and globus pallidus. These findings support the idea that both BIs and FUS-ir structures are pathological hallmarks of a subset of ALS cases. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20409561     DOI: 10.1016/j.jns.2010.03.029

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43.

Authors:  Koji Matsukawa; Tadafumi Hashimoto; Taisei Matsumoto; Ryoko Ihara; Takahiro Chihara; Masayuki Miura; Tomoko Wakabayashi; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

2.  Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.

Authors:  Ian R A Mackenzie; Olaf Ansorge; Michael Strong; Juan Bilbao; Lorne Zinman; Lee-Cyn Ang; Matt Baker; Heather Stewart; Andrew Eisen; Rosa Rademakers; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2011-05-21       Impact factor: 17.088

Review 3.  The role of FUS gene variants in neurodegenerative diseases.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

Review 4.  Fused in Sarcoma Neuropathology in Neurodegenerative Disease.

Authors:  Ian R A Mackenzie; Manuela Neumann
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

5.  Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72.

Authors:  Leeanne McGurk; Virginia M Lee; John Q Trojanowksi; Vivianna M Van Deerlin; Edward B Lee; Nancy M Bonini
Journal:  J Neuropathol Exp Neurol       Date:  2014-09       Impact factor: 3.685

Review 6.  Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.

Authors:  Ian R A Mackenzie; Manuela Neumann; Nigel J Cairns; David G Munoz; Adrian M Isaacs
Journal:  J Mol Neurosci       Date:  2011-05-21       Impact factor: 3.444

7.  Topography of FUS pathology distinguishes late-onset BIBD from aFTLD-U.

Authors:  Edward B Lee; Jenny Russ; Hyunjoo Jung; Lauren B Elman; Lama M Chahine; Daniel Kremens; Bruce L Miller; H Branch Coslett; John Q Trojanowski; Vivianna M Van Deerlin; Leo F McCluskey
Journal:  Acta Neuropathol Commun       Date:  2013-05-09       Impact factor: 7.801

8.  Targeting TNFα produced by astrocytes expressing amyotrophic lateral sclerosis-linked mutant fused in sarcoma prevents neurodegeneration and motor dysfunction in mice.

Authors:  Brigid K Jensen; Kevin J McAvoy; Nicolette M Heinsinger; Angelo C Lepore; Hristelina Ilieva; Aaron R Haeusler; Davide Trotti; Piera Pasinelli
Journal:  Glia       Date:  2022-04-26       Impact factor: 8.073

9.  ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules.

Authors:  Caroline Vance; Emma L Scotter; Agnes L Nishimura; Claire Troakes; Jacqueline C Mitchell; Claudia Kathe; Hazel Urwin; Catherine Manser; Christopher C Miller; Tibor Hortobágyi; Mike Dragunow; Boris Rogelj; Christopher E Shaw
Journal:  Hum Mol Genet       Date:  2013-03-07       Impact factor: 6.150

10.  Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.

Authors:  Jelena Scekic-Zahirovic; Oliver Sendscheid; Hajer El Oussini; Mélanie Jambeau; Ying Sun; Sina Mersmann; Marina Wagner; Stéphane Dieterlé; Jérome Sinniger; Sylvie Dirrig-Grosch; Kevin Drenner; Marie-Christine Birling; Jinsong Qiu; Yu Zhou; Hairi Li; Xiang-Dong Fu; Caroline Rouaux; Tatyana Shelkovnikova; Anke Witting; Albert C Ludolph; Friedemann Kiefer; Erik Storkebaum; Clotilde Lagier-Tourenne; Luc Dupuis
Journal:  EMBO J       Date:  2016-03-07       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.